Drug shortages

Lamivudine Tablet

ViiV Healthcare Company

To Be Discontinued49702-204-13Antiviral
Open FDA's page for this record
Discontinued date
10/19/2026
Update type
New
Initial posting date
10/19/2026
Package NDC
49702-204-13
Generic name
Lamivudine Tablet
Contact info
800-844-8872
Related info
The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
Update date
10/19/2026
Dosage form
Tablet
Presentation
Epivir, Tablet, 300 mg (NDC 49702-204-13)
Company name
ViiV Healthcare Company
Status
To Be Discontinued
Therapeutic category
Antiviral
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.